Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight key findings, such as the comparative effectiveness of ketamine and ECT in treatment-resistant major depression and the associated memory issues with ECT. Phrases like 'landmark trial' and 'game changer' illustrate a tone of excitement and urgency, indicating a strong belief in the importance of the study's results. Furthermore, specific mentions of statistics, like the 55.4% response rate for ketamine vs. 41.2% for ECT, reflect a serious consideration of the data presented.
Overall, there is moderate agreement with the study's conclusions about ketamine's effectiveness compared to ECT.
The discussions reveal a high level of interest in the findings, as many users express curiosity about the implications of the study.
While many posts reference the study, the depth of engagement varies, with some falling into more casual remarks rather than in-depth analysis.
Many users perceive the publication as having a significant impact on the treatment landscape for depression, suggesting potential shifts in clinical practice.
In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the full ELEKT-D trial Research Summary: https://t.co/fTjEfcaIWV
治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxwsiY 治療反応性は55.4%vs41.2%で、非劣性どころか優越性もありそうな数字
3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was non-inferior, but the editorial points out that "by 6 mos, a brief period in a lifetime of depression, QoL was no better than w ECT." https://t.co/PlpzUk67is https://t.co/Z4gRmqxyzA
Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV Better tolerability and slightly better response with #ketamine, but the study design favored ketamine (no psychosis, 89% outpatient). https://t.co/kkCn8JvLpT
Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demencia #MayorMortalidad #MayorMorbilidad @INCMNSZ_Geria @AMGeriatriaAC @INGER_mx Gracias @tiomorales ! Lectura obligada @TecPsychiatry https://t.co/UqaSyAd0xL https://t.co/aLiUZpq1US
Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and slightly better response rates for ketamine. Caveat: psychosis excluded (where ECT outperforms), 89% outpt, long-term effects unknown. https://t.co/9Ir0G3eopX https://t.co/0tlvv1mstR
This episode of the Ketamine Startup Podcast shares insights on opening a ketamine clinic, discussing the efficacy of IV ketamine for mental health issues. Learn about treatment resistance, especially in depression, and…
This episode covers the journey of opening a ketamine clinic with insights from a presentation by Sam at the ACEP Scientific Assembly. Learn about the efficacy of IV ketamine for treatment-resistant depression, anxiety…
RT @carlos_arnaud: @AllenFrancesMD It seems that u have never treated a suicidal patient with #ketamine Just to remind u this study: htt…
@AllenFrancesMD It seems that u have never treated a suicidal patient with #ketamine Just to remind u this study: https://t.co/fgNvx6AKmK #Ketamine is quite different as #Esketamine Assume this radical thoughts about this , you look like @joannamoncrieff
RT @kimuramoriyo: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | New England Journal of Medicine 日本の精神科医、エビデン…
RT @kimuramoriyo: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | New England Journal of Medicine 日本の精神科医、エビデン…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | New England Journal of Medicine 日本の精神科医、エビデンスない、休職診断書かいて儲けてないで、少しは勉強してくださいな。 https://t.co/9YJwUlILt5
@doc_santanu @chrisaikenmd Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | New England Journal of Medicine https://t.co/IMvzIsnjbD Dr. Santanu, in non-psychotic #TRD, #ketamine is non-inferior to #ECT as demonstrated in this #RCT published in @NEJM. Could you please post the
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
Esketamine has been shown to be superior to quetiapine by Reif et al in the @NEJM https://t.co/hJ7u6zsBRX Ketamine also non-inferior to electroconvulsive therapy (ECT) by Anand et al also in @NEJM https://t.co/fMBvU9xZvl #BAP2024
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
RT @chrisaikenmd: Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV…
Recap of last year's landmark trial comparing ECT to ketamine in treatment resistant #depression: https://t.co/XGMfXerDzV Better tolerability and slightly better response with #ketamine, but the study design favored ketamine (no psychosis, 89% outpatient). https://t.co/kkCn8JvLpT
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
"Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression" via @snikayin et al https://t.co/Pxfn7rjPBW
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
RT @psychunseen: New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equall…
New N=403 RCT published in @NEJM comparing ECT vs. IV Ketamine in refractory major depression shows both treatments equally effective (noninferior); less memory impairment with ketamine. https://t.co/BofmGyvdBr https://t.co/DhJsWTXpGa
This study aimed to compare the effectiveness of Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine when used for treatment-resistant major depression. https://t.co/Oxcmh7OkTZ https://t.co/pMcqAeKRRm
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
RT @carlos_arnaud: Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demenc…
Publicado hoy en @NEJM #DepresiónResistenteATratamiento en el #AdultoMayor Tenerla aumenta riesgo de #Suicidio #Demencia #MayorMortalidad #MayorMorbilidad @INCMNSZ_Geria @AMGeriatriaAC @INGER_mx Gracias @tiomorales ! Lectura obligada @TecPsychiatry https://t.co/UqaSyAd0xL https://t.co/aLiUZpq1US
Our blog at https://t.co/lfuCVoEBHt examines how ketamine compares to conventional medication. For a better understanding, visit https://t.co/3GlVJZ2GKN. #DestinFL #KetamineTherapy #Antidepressant https://t.co/MrKWalqIqN
RT @carlos_arnaud: @sanilrege @psycheureka Definitely first study comparing ECT vs Ketamine in TRD https://t.co/UqaSyAd0xL
RT @carlos_arnaud: @sanilrege @psycheureka Definitely first study comparing ECT vs Ketamine in TRD https://t.co/UqaSyAd0xL
@sanilrege @psycheureka Definitely first study comparing ECT vs Ketamine in TRD https://t.co/UqaSyAd0xL
RT @DrAkhilRaghavan: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression ECT & subanesthetic intravenous ketamine a…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression ECT & subanesthetic intravenous ketamine are both currently used for treatment-resistant major depression. Comparative effectiveness of the two were assessed. June 22, 2023 https://t.co/jFbOwlJ59h https://t.co/d3WWVrPYJv
RT @alokvkulkarni: Attaching #data about the #efficacy of #ketamine in the treatment of #depression. 1.https://t.co/G4DqliCPwm 2.https:/…
Attaching #data about the #efficacy of #ketamine in the treatment of #depression. 1.https://t.co/G4DqliCPwm 2.https://t.co/IOrXFnEfsd 3.https://t.co/JT7UFZQ7f4 @DrRaymondLam @rogersmcintyre @sameerjauhar @sanilrege @JD_Rosenblat #ketamine #mentalhealth #depression https://t.co/MK1JEnwMrR
This study aimed to compare the effectiveness of Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine when used for treatment-resistant major depression. https://t.co/Oxcmh7OkTZ https://t.co/NDTPtcduql
The 10/06/2023 #JournalClub presented "Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression." The recording is available free to all AAPP members. https://t.co/iOIJuC8GgR https://t.co/j90Tw2PjpF
@US_FDA @FDA @APApsychiatric @CANMAT_org @WPA_Psychiatry @rogersmcintyre @AASuicidology @Pres_APA @ECNPtweets @MCNPMexico Publicado recientemente en @NEJM la eficacia de #ketamina vs #Terapia Electroconvulsiva en #DepresiónResistenteATratamiento salió superior la #ketamina en lograr respuesta de síntomas
@IamNomad @blknoiz06 https://t.co/48yHtvfz2a
RT @DavidHathawayMD: "Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis." Congrats to D…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression #science #publication #research #publications https://t.co/O0LdUaf2Ez
Ketamine versus ECT for nonpsychotic treatment-resistant major depression Anand A, Mathew SJ, Sanacora G, et al. N Engl J Med. 2023;388(25):2315-2325. Abstract Editor: Sanjay Arora, MD PMID: 37224232
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
OL RCT: Ketamine was noninferior to ECT as therapy for TRD without psychosis (MD-response= 14.2%; 3.9%-24.2%). ECT appeared to be associated with a decrease in memory recall after 3 weeks of treatment (HVLT-R= −9.7 vs. −0.9 with ketamine) https://t.co/9u5xa5qbda https://t.co/dRXiYDnamy
今朝のJournal Clubで専行医の先生が紹介してくれました．NMDA受容体について学位研究していたことがあるので色々と思うところや考えるところがありました． https://t.co/xSJ4hAZHWq
@RettungsTaxi @narkosepadawan Es ist diese aktuelle Studie gemeint: https://t.co/iBZHF33q5h
RT @drfrogger: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタ…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/GfpLvjiZtO
#Ketamine was found to have comparable outcomes to #ECT for major #depression without psychosis. Side effects from ECT include memory recall difficulties that gradually improved, plus musculoskeletal defects. Ketamine's side effect was dissasociation. https://t.co/Q3nQD93MQu
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression - PubMed https://t.co/Y26Abpaijs
RT @NEJM: This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgM…
This week’s most shared article: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/fTjEfcbgMt #ClinicalMedicine https://t.co/7GCjT1I5Fh
先日の精神科薬物療法認定薬剤師講習会でも話題になっていましたが、うつ病に対する「ケタミン」の効果が見直されてるのかもしれませんね。 ＃ケタミン ＃うつ病 Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression - PubMed https://t.co/RgQLbien6G
@mellziland Para depressão maior, esse artigo publicado Esse mês no New England é muito promissor: https://t.co/tFS2WmCABZ
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/DrAcJ3t5PE https://t.co/Dt7DZymTEg
Keep calm and take ketamine https://t.co/GfOpsw6CMe
RT @BellevueDoc: New England Journal of Medicine: ketamine twice a week "non-inferior" to ECT three times a week. https://t.co/F6P8Otp6e5
@Biorealism @natashaloder There using it for treatment in the US, also psilocybin is Being used with pretty good results I believe. https://t.co/kXuVVr0Eoe
https://t.co/PsjCbVZQei Conclusion: "Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis".
@tomlin_ashcroft The evidence on ketamine vs ECT is very mixed, yes this study found it was better https://t.co/JunrmV8jE1 but this meta-analysis did not https://t.co/EPd3arRvIu. I don't know what glutamate > monoamine means. Neurotransmitters are not competing with each other
Ketamina versus terapia electroconvulsiva (TEC) para la depresión mayor resistente al tratamiento no psicótico: La ketamina no fue inferior a la TEC como terapia para la depresión mayor resistente al tratamiento sin psicosis. https://t.co/9lZF81EAhb https://t.co/s1OyFWLNyz
https://t.co/B3MOvPG5lJ
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
Exciting findings from the latest non-inferiority study comparing #ECT and #Ketamine for treatment-resistant #depression! A good study. However, unilateral ECT was used for comparison in a non-inferiority design. https://t.co/1mHCgEmM21
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
RT @NEJM: In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the…
In more than a third of patients with major depression, treatment with antidepressant drugs fails to control symptoms. Read the full ELEKT-D trial Research Summary: https://t.co/fTjEfcaIWV
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
@jaredpolis @kimbal Avoid promoting mental health drugs. Stay in your own fucking lane. https://t.co/kcDs049PQW
#ketamine for #majordepression https://t.co/ljV9DbNCHe #MedTwitter
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/GyQkiTk3dn
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
RT @geri_doc: Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this tria…
Potentially landmark RCT of Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. But why did this trial exclude persons over age 75? Inexusable ageism. Why didn't @PCORI demand this trial be relevant to older persons? @NEJM https://t.co/fYuLVzCAIF
RT @anarlfasso: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tLwCzwQyQt
Interesante tema y es un artículo para entender la no inferioridad. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/MT5T7azizL
RT @drchadb: The work of Dr. Domino continues to impact care today as a novel treatment for #depression He would be energized, curious and…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tLwCzwQyQt
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. N Engl J Med 2023;388:2315-25 https://t.co/H91xpNcn74
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/IathbP0I45
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/MazAEfoCG9
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM #methods " The open-label design of our trial could have influenced response." https://t.co/wT8HETEsm8
"Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/w4UWqCVB8W
good gay news for pride
OL RCT: Ketamine was noninferior to ECT for TRD without psychosis. Resposne rate (55.4% vs. 41.2%; MD=14.2%; 3.9-24.2). ECT appeared to be associated with a decrease in memory recall after 3 weeks (mean decrease - HVLT-R= −9.7 vs. −0.9 with ketamine) https://t.co/aK4y8PsoVl
RT @AliAsgharAliMD: Hurray! Defining study comparing ECT and ketamine published. Fortunate to have been a Co-I on the study. Check it out -…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/2HuqGJNXGq
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/ybaGEwCc2x
The authors of this impressive NEJM study write: "BACKGROUND Electroconvulsive therapy (ECT) https://t.co/H7zZ1dHVao https://t.co/jYQ7QpGw3W
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/2HuqGJNXGq
RT @AliAsgharAliMD: Hurray! Defining study comparing ECT and ketamine published. Fortunate to have been a Co-I on the study. Check it out -…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/JGxueu9G64
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/MrKhn8NMIF
RT @HiromasaFunato: 効果折り紙付きのECTに全く劣らぬ効果を見せつけたケタミン...すごい 麻酔薬と併用して解離体験を経験しないようにすると抗うつ効果が認められないという報告（とても不完全な研究だけど）もあって解離の効果も関係しているのかも https:/…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/LFfOYuklZg
RT @AliAsgharAliMD: Hurray! Defining study comparing ECT and ketamine published. Fortunate to have been a Co-I on the study. Check it out -…
El ensayo clínico, basado en las experiencias de 403 pacientes, comparó efectos del uso de TEC y de ketamina para tratar los síntomas de la depresión mayor y encontró que el 55% de la gente que recibió K reportó mejoras en sus síntomas y calidad de vida https://t.co/4Twjcn5wNk
RT @MichaelFarrellE: Big study showing non inferiority of Ketamine vs ECT. Important finding! @ProfRobHoward Ketamine versus ECT for Nonpsy…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/q0JgZvTDwo
RT @AliAsgharAliMD: Hurray! Defining study comparing ECT and ketamine published. Fortunate to have been a Co-I on the study. Check it out -…
Hurray! Defining study comparing ECT and ketamine published. Fortunate to have been a Co-I on the study. Check it out - is ketamine as good, worse, better?! https://t.co/tusnJKDEwn @BCMPsychRes @BCM_DEIT @BCM_GeriPalli @PsychSIGN @SCMirecc @IQuEStHouston @PCORI #ketamine #ect https://t.co/UFVmWw7tdE
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/MHJ0tERXqa Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis. At least hopeful
RT @madras_bertha: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/dMOljJP5MF
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/dMOljJP5MF
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/XFPghsoVYF
RT @MichaelFarrellE: Big study showing non inferiority of Ketamine vs ECT. Important finding! @ProfRobHoward Ketamine versus ECT for Nonpsy…
Big study showing non inferiority of Ketamine vs ECT. Important finding! @ProfRobHoward Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/uQx1xN3P7r
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/Iwrqjli7JK
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/OuV1U2anDx
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
RT @drfrogger: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタ…
RT @drfrogger: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタ…
RT @drfrogger: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタ…
RT @drfrogger: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタ…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/tVSedypJD0 ケタミンと電気けいれん療法の比較、ケタミンは非劣性で副作用も少なめっぽいね。
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/OrZmcQ0way
RT @HiromasaFunato: 効果折り紙付きのECTに全く劣らぬ効果を見せつけたケタミン...すごい 麻酔薬と併用して解離体験を経験しないようにすると抗うつ効果が認められないという報告（とても不完全な研究だけど）もあって解離の効果も関係しているのかも https:/…
RT @CarlatPsych: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability, slightly…
RT @CarlatPsych: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability, slightly…
Συμπεράσματα: Η κεταμίνη δεν ήταν κατώτερη από το ECT ως θεραπεία για ανθεκτική στη θεραπεία μείζονα κατάθλιψη χωρίς ψύχωση! https://t.co/pmufWDdZtQ
RT @CarlatPsych: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability, slightly…
効果折り紙付きのECTに全く劣らぬ効果を見せつけたケタミン...すごい 麻酔薬と併用して解離体験を経験しないようにすると抗うつ効果が認められないという報告（とても不完全な研究だけど）もあって解離の効果も関係しているのかも https://t.co/ecbGNyfSvm https://t.co/kroawNTSL8
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
RT @chrisaikenmd: Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and sligh…
Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability and slightly better response rates for ketamine. Caveat: psychosis excluded (where ECT outperforms), 89% outpt, long-term effects unknown. https://t.co/9Ir0G3eopX https://t.co/0tlvv1mstR
Landmark @NEJM trial compared ECT to ketamine in 403 pt w/ treatment resistant #depression. Better tolerability, slightly better response rates for ketamine. Caveat: psychosis excluded (where ECT outperforms), 89% outpt, long-term effects unknown -C Aiken https://t.co/rl8plDzxLn https://t.co/O2ZxVQIe2w
RT @agingdoc1: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
"Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis." Congrats to Dr. Anand, et al, on Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/XYn32T4yNp
RT @pash22: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/MvKrdlZUkM via @JMurrough et al
RT @agingdoc1: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/MvKrdlZUkM via @JMurrough et al
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/vbCl0i5Adl
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/CoU5PC1IHV
expert reaction to trial looking at ketamine versus ECT for nonpsychotic treatment-resistant major depression | Science Media Centre https://t.co/ReXb0l8oK8 #ECT #ketamine #depression
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM - https://t.co/vIRovKNVNf https://t.co/uFuu96QhXn #TrendingNow #HotTopics #Trending #News #NewsUpdate #MyForumLink #BreakingNews
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM - https://t.co/kCQ2SHHo0a [via @googlenews] https://t.co/7QMaVglHUs https://t.co/q7H6qhPX5t
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @OxPsychiatry: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/7JYPKp6qsb
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM - https://t.co/vIRovKNnXH https://t.co/cKg3RDd9Mf #TrendingNow #HotTopics #Trending #News #NewsUpdate #MyForumLink #BreakingNews
Ketamine performs at least as well as ECT in treatment-resistant depression, study says | Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/K3jdjiEQ2X
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @OxPsychiatry: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/7JYPKp6qsb
https://www.sciencemediacentre.org/expert-reaction-to-trial-looking-at-ketamine-versus-ect-for-nonpsychotic-treatment-resistant-major-depression/
Sense of relief experienced by those who find out they will only need to take ketamine and not get ECT is enough to significantly lessen their depression. https://t.co/03Ozwz2r3y
expert reaction to trial looking at ketamine versus ECT for nonpsychotic treatment-resistant major depression, as published in the NEJM https://t.co/RmdldB8ve0
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @rogersmcintyre: This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
This is the most compelling head to head comparison of ECT and IV ketamine to date in outpatient adults with treatment resistant depression: ketamine not inferior to ECT and had trend for therapeutic advantages on patient reported outcomes https://t.co/RW0AJr2j9G
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM - https://t.co/kCQ2SHHo0a [via @googlenews] https://t.co/J1J7qdJNJS https://t.co/u788QItyzD
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression ➡️ Now on https://t.co/4IEyOjfzA1 — https://t.co/ym3D4mx7sl
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/LadgsErUwC
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression | NEJM https://t.co/h8SasPrUXm
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
RT @MarkOldhamMD: 3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was n…
RT @EARL_med_tw: 治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxws…
治療抵抗性のうつ病に対するケタミン（0.5mg/kgを40分間で週2回）は，電気痙攣療法（週3回）に比して非劣性（マージンは-10%）．403例RCT（N Engl J Med 2023 May24） https://t.co/eQWQLxwsiY 治療反応性は55.4%vs41.2%で、非劣性どころか優越性もありそうな数字
3-wk randomized non-inferiority trial of ketamine vs ECT for tx-resistant depression + 6-mos f/u (PCORI). Ketamine was non-inferior, but the editorial points out that "by 6 mos, a brief period in a lifetime of depression, QoL was no better than w ECT." https://t.co/PlpzUk67is https://t.co/Z4gRmqxyzA
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression https://t.co/7JYPKp6qsb
RT @benryanwriter: Study finds ketamine is at least as effective as ECT for treating major depression A trial of 403 patients found that 55…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @benryanwriter: Study finds ketamine is at least as effective as ECT for treating major depression A trial of 403 patients found that 55…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @benryanwriter: Study finds ketamine is at least as effective as ECT for treating major depression A trial of 403 patients found that 55…
Study finds ketamine is at least as effective as ECT for treating major depression A trial of 403 patients found that 55% of those who received ketamine treatment experienced a sustained improvement in depressive symptoms without major side effects. https://t.co/Wwq9WnvazL
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
RT @medical_xpress: Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrig…
Study finds #ketamine is at least as effective as electroconvulsive therapy for treating major #depression @MassGenBrigham @nejm https://t.co/6jU9vdpMft https://t.co/MRAky1iCHY